The researchers found that no rise of blood glucose levels in diabetic or normal subjects accompanied ingestion of the D-tagatose at doses ranging from 10 to 75 grams. Furthermore, they confirmed their earlier indication that, when D-tagatose is taken before glucose, the normally expected rise in blood glucose is significantly blunted. The glucose blunting effect continued for at least two hours after consumption of the tagatose. No toxic effects were observed in either group of subjects. These early findings suggest that D-tagatose may be useful for patients with diabetes in improving their diabetic control.
Early indications are favorable.
In other developments, Company officials announced that the Board of Directors, in its November Meeting, elected Mr. Thomas W. Gantt to fill the Board seat vacated by the resignation of Mr. A. Bruce Cleveland. Mr. Gantt, who served Biospherics as a financial consultant in 1999, formerly held positions of chief financial officer and other senior management positions in several corporations. Biospherics offers telecommunications call centers, information systems, database management, and proprietary food and medical innovations.